Clinical Trials Directory

Trials / Completed

CompletedNCT01935206

Effect of High Dose Naloxone on Secondary Hyperalgesia

Effect of a High-dose Naloxone Infusion on Secondary Hyperalgesia After a First-degree Burn

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
Male
Age
20 Years – 35 Years
Healthy volunteers
Accepted

Summary

Recent studies have focused on the role of endogenous opioids on central sensitization. Central sensitization is known to be impaired or altered in chronic pain conditions, as fibromyalgia or chronic tension headache. Animal studies have shown reinstatement of mechanical hypersensitivity following naloxone administration after resolution of an injury. This suggests latent sensitization. In the present study, investigators hypothesize that naloxone (2 mg/kg) can reinstate secondary hyperalgesia 168 hours after a first-degree burn-injury. Investigators aim therefore to show that latent sensitization is present in humans and is modulated by endogenous opioids.

Conditions

Interventions

TypeNameDescription
DRUGNaloxone (2 mg/kg)
DRUGPlacebo

Timeline

Start date
2013-06-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2013-09-05
Last updated
2014-02-25

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01935206. Inclusion in this directory is not an endorsement.